Partnering with Big Pharma-What Academics Need to Know.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 27104971.
- Also identified by DOI 10.1016/j.cell.2016.04.021.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Knowledge of the parameters of drug development can greatly aid academic scientists hoping to partner with pharmaceutical companies. Here, we discuss the three major pillars of drug development-pharmacodynamics, pharmacokinetics, and toxicity studies-which, in addition to pre-clinical efficacy, are critical for partnering with Big Pharma to produce novel therapeutics.
Medical subject headings
- Drug Delivery Systems
- Drug Design